Chimerix, Inc. announced the appointment of Heather Knight-Trent, PharmD, as vice president of regulatory affairs. Dr. Knight-Trent brings more than 15 years of pharmaceutical regulatory experience to the company and will be responsible for managing all U.S. and global regulatory matters for the company, including strategy, filings and interactions with regulatory authorities. Dr. Knight-Trent was previously executive director of regulatory affairs at Hurley Consulting Associates, where she was responsible for regulatory strategy and implementation for multiple clients. She was previously at Bristol Myers Squibb for ten years in roles both in the U.S. and Europe, most recently as the director of global regulatory, safety and biometrics business operations. In this role Dr. Knight-Trent supported the vice presidents of global regulatory strategy for all therapeutic areas on resourcing, budget, group capabilities and continuous improvement projects.